Roche Pill Images - Pill Identifier - Drugs.com
WEBPill Identifier results for "roche". Search by imprint, shape, color or drug name.
How Roche passed on a potential $14bn-a-year weight-loss pill
WEBAug 15, 2024 · Swiss drugmaker Roche turned down a potential $14bn-a-year weight-loss pill now being developed by rival Eli Lilly that could have given it a leading position in the booming weight-loss...
Roche Moves Ahead With Once-Daily Weight Loss Pill - Forbes
WEBJul 17, 2024 · Roche is developing the pill to treat obesity and type 2 diabetes and the company said it plans to advance to mid-stage trials based on the preliminary results.
Roche to fast-track weight-loss pill to compete with rivals
WEBJul 29, 2024 · Roche plans to fast-track its anti-obesity drugs to challenge rivals Eli Lilly and Novo Nordisk in the booming market after unveiling promising data for a weight-loss pill.
Roche Obesity Pill Achieves Positive Results in Early-Stage Trial
WEBJul 17, 2024 · Roche said a new weight-loss pill under development achieved positive results in an early-stage clinical trial, bolstering the company’s efforts to enter the booming obesity market after another...
Roche Jumps After Weight-Loss Pill Shows Promise in Study - MSN
WEB(Bloomberg) -- Roche Holding AG shares jumped after its experimental weight loss pill showed meaningful weight reduction in an early stage study among obesity patients, setting up the Swiss...
Roche Shares Drop on Concern About Obesity Pill Side Effects
WEBSep 11, 2024 · Roche dropped as much as 5% in early trading in Zurich on Thursday after releasing results of a small study that showed high rates of nausea and vomiting, as well as other side effects.
Roche touts early trial success of second obesity drug candidate
WEBJul 17, 2024 · Roche's experimental once-daily pill CT-996 resulted in a placebo-adjusted average weight loss of 6.1% within four weeks in obese patients without diabetes in a Phase I trial, Roche said in...
Roche to accelerate Wegovy weight loss rivals after positive trials
WEBJul 29, 2024 · Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Novo Nordisk, Eli Lilly shares slide on Roche's obesity drug trial
WEBJul 17, 2024 · Key Points. Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate. Roche said its experimental once-daily pill showed...